Yohimbine Stress Moderates the Relationship Between Opioid Craving and Seeking Behavior

The linkage between drug craving and seeking behavior is theoretically and clinically important but poorly understood. This secondary data analysis examined the association between opioid craving and seeking in regular heroin users exposed to the pharmacological stressor yohimbine. We hypothesized that acute noradrenergic activation would strengthen the opioid craving/seeking linkage, such that opioid craving would be positively associated with seeking during yohimbine but not placebo. Participants ( N = 21) were out-of-treatment, chronic regular heroin users stabilized on buprenorphine 8 mg/day, which suppressed baseline withdrawal symptoms. Across two similar studies, participants were pretreated with oral yohimbine (32.4 mg; NCT00684840: Study 1, n = 10] or 27 mg; NCT01536925: Study 2, n = 11]) or placebo on different session days under randomized, double-blinded conditions, and could work (progressive ratio schedule; 12 trials/session) to earn units of IM hydromorphone (1.5 mg/trial) or money ($2/trial). Opioid craving and vital signs were repeatedly measured each session. A two-level moderation model examined the relationship between opioid craving and seeking and whether the relationship differed as a function of placebo vs. yohimbine challenge. As hypothesized, exposure to yohimbine significantly moderated the relationship between opioid craving and opioid-seeking behavior. Increased systolic blood pressure relative to each participant’s mean level similarly acted as a moderator, indicating the role of physiological stress as a link between craving and seeking. These findings support the idea that acute noradrenergic activation, a key driver of the physiological stress response, facilitates increased risk of opioid use, independent of withdrawal symptoms.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11235755/v1
Primary Topic
Opioid Use Disorder Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Yohimbine Stress Moderates the Relationship Between Opioid Craving and Seeking Behavior

Mark K. Greenwald, Nicole A. Kouri
Research Square
Opioid Use Disorder Treatment
preprint

Yohimbine Stress Moderates the Relationship Between Opioid Craving and Seeking Behavior

Mark K. Greenwald, Nicole A. Kouri
preprint en

Abstract

The linkage between drug craving and seeking behavior is theoretically and clinically important but poorly understood. This secondary data analysis examined the association between opioid craving and seeking in regular heroin users exposed to the pharmacological stressor yohimbine. We hypothesized that acute noradrenergic activation would strengthen the opioid craving/seeking linkage, such that opioid craving would be positively associated with seeking during yohimbine but not placebo. Participants ( N = 21) were out-of-treatment, chronic regular heroin users stabilized on buprenorphine 8 mg/day, which suppressed baseline withdrawal symptoms. Across two similar studies, participants were pretreated with oral yohimbine (32.4 mg; NCT00684840: Study 1, n = 10] or 27 mg; NCT01536925: Study 2, n = 11]) or placebo on different session days under randomized, double-blinded conditions, and could work (progressive ratio schedule; 12 trials/session) to earn units of IM hydromorphone (1.5 mg/trial) or money ($2/trial). Opioid craving and vital signs were repeatedly measured each session. A two-level moderation model examined the relationship between opioid craving and seeking and whether the relationship differed as a function of placebo vs. yohimbine challenge. As hypothesized, exposure to yohimbine significantly moderated the relationship between opioid craving and opioid-seeking behavior. Increased systolic blood pressure relative to each participant’s mean level similarly acted as a moderator, indicating the role of physiological stress as a link between craving and seeking. These findings support the idea that acute noradrenergic activation, a key driver of the physiological stress response, facilitates increased risk of opioid use, independent of withdrawal symptoms.

Research Square
Wayne State University (US)
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon